Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

12 Dec, 09:54 - Indian

SENSEX 81569.66 (0.05)

Nifty 50 24642.85 (0.00)

Nifty Bank 53379.65 (-0.02)

Nifty IT 45952 (1.33)

Nifty Midcap 100 59355.1 (0.10)

Nifty Next 50 73268.7 (-0.03)

Nifty Pharma 22364.9 (0.28)

Nifty Smallcap 100 19656.4 (0.00)

12 Dec, 09:54 - Global

NIKKEI 225 39917.58 (1.39)

HANG SENG 20501.14 (1.72)

S&P 6096.25 (-0.14)

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals |

(28-Nov-24 10:11) Dr Reddy's Labs launches immuno-oncology drug Toripalimab in India
(28-Nov-24 09:14) Dr Reddys launches immuno-oncology drug - Toripalimab in India
(21-Nov-24 10:23) DRL slips after Hyderabad facility gets 7 observations from USFDA
(20-Nov-24 10:40) DRL’s Hyderabad facility gets 7 observations from USFDA
(14-Nov-24 09:22) Mexican health regulator imposes penalty on Dr Reddy's
(06-Nov-24 13:05) Dr Reddys Laboratories Ltd spurts 2.25%
(05-Nov-24 17:35) Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore
(05-Nov-24 17:09) Dr Reddy's Laboratories consolidated net profit declines 15.28% in the September 2024 quarter
(08-Oct-24 18:16) Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
(05-Oct-24 11:37) Dr Reddys announces incorporation of new step-down subsidiary in Denmark

1 2 3 4 5 6 7 8 9 10

Dr Reddys Laboratories Ltd